IQVIA Holdings Inc (QTS)
TG
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-02-13 | Mr. Bernard HaasExec. VP of AI & Technology Solutions | -20.00 | 3.34k | Sale to Issuer | 166.94 | 17.02k | -0.12% |
| 2026-02-13 | Mr. Michael J. FedockExec. VP & CFO | -123.00 | 20.53k | Sale to Issuer | 166.94 | 6.63k | -1.82% |
| 2026-02-08 | Mr. Bernard HaasExec. VP of AI & Technology Solutions | -440.00 | 82.50k | Sale to Issuer | 187.49 | 16.67k | -2.57% |
| 2026-02-08 | Mr. Alistair GrenfellPresident of Commercial Solutions | -5.55k | 1.04M | Sale to Issuer | 187.49 | 24.12k | -18.69% |
| 2026-02-07 | Mr. Michael J. FedockExec. VP & CFO | -2.53k | 474.54k | Sale to Issuer | 187.49 | 6.47k | -28.13% |
| 2026-02-08 | Mr. Bhavik PatelPresident of MedTech & Consumer Health | -1.92k | 359.98k | Sale to Issuer | 187.49 | 3.20k | -37.48% |
| 2026-02-08 | Mr. Eric M. SherbetExec. VP, General Counsel & Secretary | -1.92k | 359.04k | Sale to Issuer | 187.49 | 26.00k | -6.86% |
| 2026-02-08 | Mr. W. Richard StaubPresident of Research & Development Solutions | -806.00 | 151.12k | Sale to Issuer | 187.49 | 18.81k | -4.11% |
| 2026-02-08 | Ms. Keriann CherofskySenior VP, Corporate Controller & CAO | -415.00 | 77.81k | Sale to Issuer | 187.49 | 1.09k | -27.57% |
| 2026-02-08 | Mr. Ronald E. Bruehlmanインサイダー | -6.80k | 1.28M | Sale to Issuer | 187.49 | 56.00k | -10.83% |
| 2026-02-08 | Mr. James G. BerkshireExec. VP of Global Infrastructure & Operations | -1.28k | 239.99k | Sale to Issuer | 187.49 | 8.18k | -13.53% |
| 2026-02-08 | Mr. Ari BousbibCEO & Chairman | -28.40k | 5.32M | Sale to Issuer | 187.49 | 1.38M | -2.02% |
| 2026-01-28 | Mr. Michael J. FedockExec. VP & CFO | -381.00 | 91.35k | Sale to Issuer | 239.76 | 1.88k | -16.89% |
| 2025-12-18 | Mr. Ari BousbibCEO & Chairman | -50.00k | 8.13M | Derivative Exercise and Sale | 59.90 - 222.91 | 1.35M | - |
| 2025-10-29 | Mr. Eric M. SherbetExec. VP, General Counsel & Secretary | -10.00k | 878.92k | Derivative Exercise and Sale | 131.82 - 219.72 | 21.11k | - |
| 2025-10-29 | Mr. Ari BousbibCEO & Chairman | -77.59k | 12.46M | Derivative Exercise and Sale | 59.90 - 221.97 | 1.35M | - |
| 2025-07-28 | Mr. Bhavik PatelPresident of MedTech & Consumer Health | -84.00 | 16.61k | Sale to Issuer | 197.76 | 1.04k | -7.47% |
| 2025-07-28 | Ms. Keriann CherofskySenior VP, Corporate Controller & CAO | -35.00 | 6.92k | Sale to Issuer | 197.76 | 418.00 | -7.73% |
| 2025-07-23 | Ms. Keriann CherofskySenior VP, Corporate Controller & CAO | -549.00 | 105.15k | 売り | 191.53 | 353.00 | -60.86% |
| 2025-07-23 | Mr. Eric M. SherbetExec. VP, General Counsel & Secretary | -11.87k | 1.10M | Derivative Exercise and Sale | 97.20 - 190.10 | 21.11k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。